Abstract:Abstract: The consequences of the transferred new coronavirus infection are currently not well understood, but the neurotropicity of SARS-CoV-2 is beyond doubt. In the manifestations of postcoid syndrome, damage to the central nervous system is dominant and requires timely diagnosis and correction, incl. at the rehabilitation stage of medical care. The introduction of highly effective non-drug methods of treatment with a small number of side effects is an urgent task of modern medicine. Such methods of treatment can include ozone therapy - the use of an ozone-oxygen mixture (ACS) for therapeutic purposes, which significantly improves blood microcirculation and oxygenation of ischemic tissues due to its fibrinolytic activity and antiaggregatory properties, and therapeutic doses of ozone are able to correct the lipid profile of patients due to reducing atherogenic lipoproteins, triglycerides and cholesterol. In the range of therapeutic concentrations, ozone exhibits immunomodulatory, anti-inflammatory, bactericidal, antiviral, and detoxification effects. This article presents the experience of using ozone therapy in patients who have undergone covid-associated pneumonia (CT1-CT4) with postcoid syndrome and a predominant lesion of the central nervous system. The analysis of the dynamics of symptoms in a group of patients who underwent a course of ozone therapy in comparison with a group where ozone therapy was contraindicated is presented. The defeat of the central nervous system was represented by the following syndromes and symptoms, both individually and in combination: - cerebrasthenic syndrome, incl. anxiety, insomnia, decreased or lack of appetite, unstable mood background, weakness, fatigue - 94% - cerebral syndrome (headaches, constant "fog in the head", less often dizziness, decreased memory and attention, impaired sensitivity like anosmia, hyposmia) - 62%, incl. loss of memory and attention was observed in 42%, anosmia and hyposmia occurred in 11% of cases. The severity of certain symptoms was manifested depending on the age, the severity of the disease, the timing of the beginning of rehabilitation measures and the comorbid background. Diagnostics of the lesion of the central nervous system by coronavirus in patients was carried out by the methods of questioning complaints, dynamic observation, using the questionnaire for assessing the quality of life EQ-5D. In addition, in both groups of patients, the assessment of the severity of the main syndromes in points from 0 to 10 was carried out using a questionnaire at the beginning of the rehabilitation course and at the end of it. Evaluation of the results at discharge was carried out using the Pearson correlation coefficient. The use of an ozone-oxygen gas mixture in a comprehensive rehabilitation program for patients with postcoid syndrome and a predominant CNS lesion can reduce the intensity or completely stop cerebroasthenic and cerebral syndromes, completely restore taste and smell, and improve certain cognitive functions. This will improve the quality of life of patients, their social adaptation and reduce the drug load. The syndromic complex of CNS lesions, which remains in a certain volume, even after a comprehensive rehabilitation program with ozone therapy, indicates the need for long-term follow-up, clinical examination and medical rehabilitation of patients after a new coronavirus infection.

[Respiratory disorders of post-COVID-19 syndrome]

Bronchodilator response in Post-COVID-19 patients undergoing pulmonary rehabilitation

Efficacy of inhaled corticosteroid and bronchodilator in patients with persistent respiratory symptoms post COVID-19 infection: a retrospective analysis

Clinico-radiological and pulmonary function assessment of post-COVID-19 patients with respiratory symptoms

[Dyspnea in post-COVID-19 patients: A review]

EVALUATION OF VENTILATION DURING EXERCISE TESTS IN PEOPLE WITH POST-COVID-19 SYNDROME

Longitudinal changes of diffusing capacity (DLCO) and dyspnoea after mild COVID-19

Impact of Coronavirus Disease 2019 on Pulmonary Function in Early Convalescence Phase

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

Oxygen consumption physical activity and fatigue in patients with pulmonary involvement post-COVID-19: A cross-sectional study

[Physiological assessment and management of post-COVID patients with normal cardiopulmonary imaging and functional tests]

Effects of a respiratory and neurological rehabilitation treatment plan in post Covid-19 affected university students. Randomized clinical study

Small airway disease in post-acute COVID-19 syndrome, a non-conventional approach in three years follow-up of a patient with long COVID: a case report

Pulmonary Function, Computed Tomography Lung Abnormalities, and Small Airway Disease after COVID-19: 3-, 6-, and 9-Month Follow-Up

Corticosteroid treatment for persistent pulmonary infiltrates following COVID-19 infection: Clearing the fog?

Effectiveness of Respiratory Rehabilitation in COVID-19's Post-Acute Phase: A Systematic Review

THE EFFECTIVENESS OF OZONE THERAPY IN THE REHABILITATION OF PATIENTS WITH DISORDERS OF THE CENTRAL NERVOUS SYSTEM AFTER SUFFERING COVID-ASSOCIATED PNEUMONIA

Sex-specific differences of cardiopulmonary fitness and pulmonary function in exercise-based rehabilitation of patients with long-term post-COVID-19 syndrome

Lung morphology changes in patients with COVID-induced acute respiratory distress syndrome depending on the respiratory therapy options

Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management